Roger Franklin holds a Ph.D. in oncology from the University of Cambridge. Roger has more than 15 years of experience in the life science industry, including positions as a senior analyst in pharmaceuticals and biotech at a London-based investment bank and as an investment manager at a large London-based life science venture capital fund. Roger currently serves as a Partner at Hadean Ventures, a Stockholm/Oslo-based European life science venture fund.